Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.BioSante Pharmaceuticals has received notification from the Nasdaq stock market that BioSante's common stock is approved for listing on the Nasdaq global market.
Subscribe to our email newsletter
BioSante’s board of directors has approved the decision to switch the listing of BioSante’s common stock from the American Stock Exchange to the Nasdaq stock global market. BioSante’s common stock will continue to trade on the American Stock Exchange under its current symbol BPA until such date.
Phillip Donenberg, CFO of BioSante, said: “We believe that Nasdaq’s electronic multiple market maker structure will provide BioSante with enhanced exposure and liquidity, while at the same time provides investors with the fastest execution and lowest cost per trade. This makes the move to Nasdaq a logical step and we expect a very orderly transfer.”